title: Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis.
abstract: Tuberculosis (TB) remains one of the most important infectious diseases of man and animals, and the only available vaccine (BCG) requires urgent replacement or improvement. To facilitate this, the protective mechanisms induced by BCG require further understanding. As a live attenuated vaccine, persistence of BCG bacilli in the host may be a crucial mechanism. We have investigated the long term persistence of BCG following vaccination and the influence on the induced immune response and protection, using an established murine model. We sought to establish whether previously identified BCG-specific CD4 TEM cells represent genuine long-lived memory cells of a relatively high frequency, or are a consequence of continual priming by chronically persistent BCG vaccine bacilli. By clearing persistent bacilli, we have compared immune responses (spleen and lung CD4: cytokine producing T effector/TEM; TCR-specific) and BCG-induced protection, in the presence and absence of these persisting vaccine bacilli. Viable BCG bacilli persisted for at least 16 months post-vaccination, associated with specific CD4 T effector/TEM and tetramer-specific responses. Clearing these bacilli abrogated all BCG-specific CD4 T cells whilst only reducing protection by 1log10. BCG may induce two additive mechanisms of immunity: (i) dependant on the presence of viable bacilli and TEM; and (ii) independent of these factors. These data have crucial implications on the rational generation of replacement TB vaccines, and the interpretation of BCG induced immunity in animal models.
authors.affiliation: Vaccine Immunology Team, Department of Bacteriology, Animal and Plant Health Agency (APHA) Addlestone KT15 3NB, Surrey, UK.
authors.forename: Daryan A
authors.initials: DA
authors.lastname: Kaveh
authors.affiliation: Vaccine Immunology Team, Department of Bacteriology, Animal and Plant Health Agency (APHA) Addlestone KT15 3NB, Surrey, UK.
authors.forename: M C
authors.initials: MC
authors.lastname: Garcia-Pelayo
authors.affiliation: Vaccine Immunology Team, Department of Bacteriology, Animal and Plant Health Agency (APHA) Addlestone KT15 3NB, Surrey, UK. Electronic address: philip.hogarth@apha.gsi.gov.uk.
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Hogarth
mesh_terms: D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D002353:Carrier State / Q000382:microbiology*; D005260:Female; D007156:Immunologic Memory; D008807:Mice, Inbred BALB C; D023421:Models, Animal; D009163:Mycobacterium bovis / Q000276:immunology* / Q000502:physiology*; D014376:Tuberculosis / Q000517:prevention & control*
chemical_list: D001500:BCG Vaccine